Adriano De Marino
Research Subjects
Adriano De Marino has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Puya G. Yazdi
Research & Development, Omics Edge, Miami, FL, USA.
5 shared publications - Abdallah Amr Mahmoud
Research & Development, Omicsedge, Miami, USA
4 shared publications - Andrew Terpolovsky
Research & Development, Omicsedge, Miami, USA
4 shared publications - Biljana Novković
Research & Development, Omicsedge, Miami, USA
4 shared publications - Sandra Bohn
State Fisheries Genomics Lab Coastal Oregon Marine Experiment Station Department of Fisheries and Wildlife Hatfield Marine Science Center Oregon State University Newport OR USA
4 shared publications Charlie Manson
Research & Development
3 shared publications
Latest Publications
- Open Access
Optimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models
Background: Polygenic risk scores (PRS) have ushered in a new era in genetic epidemiology, offering insights into individual predispositions to a wide range of diseases. However, despite recent marked enhancements in their predictive power, there are still challenges that need to be overcome before PRS-based models can be broadly applied in the clinic, including sufficient accuracy, easy interpretability and portability across diverse populations. Methods: Leveraging trans-ancestry genome-wide association study (GWAS) meta-analysis, we generated novel, diverse summary statistics for 30 medically-related traits which were used to benchmark the performance of six existing PRS algorithms using UK biobank. Observing that SBayesRC had the best overall performance but recognizing strengths in each method, we developed an ensemble PRS model using logistic regression to combine outputs from top-performing algorithms. This ensemble model was validated on the diverse eMERGE and PAGE MEC cohorts, and the performance was compared against current state-of-the-art PRS models. To enhance predictive accuracy for clinical application, we incorporated easily-accessible clinical characteristics such as age, gender, ancestry and risk factors, creating disease prediction models intended as prospective diagnostic tests, with easily interpretable positive or negative outcomes. Results: Predictive performance of PRS models improved with trans-ancestry GWAS meta-analysis and was further enhanced by the ensemble model, which surpassed state-of-art PRS models. When applied to external cohorts, performance drops were minimal, indicating good calibration. After adding clinical characteristics, 12 out of 30 models surpassed 80% AUC. Further, 25 traits exceeded the diagnostic odds ratio (DOR) of 5 and 19 traits exceeded DOR of 10 for all ancestry groups, indicating high predictive value. The highest DOR in a population with a sufficient number of cases was 66.2 for Alzheimer’s disease in Europeans. Our PRS model for coronary artery disease identified 55-80 times more true coronary events than rare pathogenic variant models, reinforcing its clinical potential. The polygenic component modulated the effect of high-risk rare variants, stressing the need to consider all genetic components in clinical settings. Conclusions: Newly developed PRS-based disease prediction models have sufficient accuracy and portability to warrant consideration of being used in the clinic.
Open AccessOptimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models
Background: Polygenic risk scores (PRS) have ushered in a new era in genetic epidemiology, offering insights into individual predispositions to a wide range of diseases. However, despite recent marked enhancements in their predictive power, there are still challenges that need to be overcome before PRS-based models can be broadly applied in the clinic, including sufficient accuracy, easy interpretability and portability across diverse populations. Methods: Leveraging trans-ancestry genome-wide association study (GWAS) meta-analysis, we generated novel, diverse summary statistics for 30 medically-related traits which were used to benchmark the performance of six existing PRS algorithms using UK biobank. Observing that SBayesRC had the best overall performance but recognizing strengths in each method, we developed an ensemble PRS model using logistic regression to combine outputs from top-performing algorithms. This ensemble model was validated on the diverse eMERGE and PAGE MEC cohorts, and the performance was compared against current state-of-the-art PRS models. To enhance predictive accuracy for clinical application, we incorporated easily-accessible clinical characteristics such as age, gender, ancestry and risk factors, creating disease prediction models intended as prospective diagnostic tests, with easily interpretable positive or negative outcomes. Results: Predictive performance of PRS models improved with trans-ancestry GWAS meta-analysis and was further enhanced by the ensemble model, which surpassed state-of-art PRS models. When applied to external cohorts, performance drops were minimal, indicating good calibration. After adding clinical characteristics, 12 out of 30 models surpassed 80% AUC. Further, 25 traits exceeded the diagnostic odds ratio (DOR) of 5 and 19 traits exceeded DOR of 10 for all ancestry groups, indicating high predictive value. The highest DOR in a population with a sufficient number of cases was 66.2 for Alzheimer’s disease in Europeans. Our PRS model for coronary artery disease identified 55-80 times more true coronary events than rare pathogenic variant models, reinforcing its clinical potential. The polygenic component modulated the effect of high-risk rare variants, stressing the need to consider all genetic components in clinical settings. Conclusions: Newly developed PRS-based disease prediction models have sufficient accuracy and portability to warrant consideration of being used in the clinic.
- Open Access
Selphi: Empowering GWAS Discovery through Enhanced Genotype Imputation
Motivation: Genotype imputation is a powerful tool for inferring missing genotype data in large-scale genomic studies. Over the last two decades, multiple research groups have developed a number of imputation algorithms, which continue improving in speed and overall accuracy. However, accurate imputation of rare and infrequent variants remains a challenge. Results: Here we present Selphi, a novel genotype imputation algorithm based on the Positional Burrow Wheeler Transform (PBWT) and a new heuristic method for haplotype selection based on identity by descent (IBD). When compared to state-of-the-art methods Beagle5.4, IMPUTE5, and Minimac4, Selphi showed a higher accuracy in 1000 Genome Project and TOPmed datasets, across all super-populations and allele frequencies. Similarly, Selphi performed better than Beagle5.4 in the UK Biobank dataset, which translated into improved GWAS discovery and more accurate polygenic risk scores. Selphi’s improvements in imputation accuracy, especially for rare and low frequency variants, promises to boost the power and accuracy of downstream genomic applications. Availability and implementation: Selphi code is available at GitHub: https://github.com/selfdecode/rd-imputation-selphi . Additionally, we offer an applet that allows convenient testing of the Selphi code on the UKB RAP platform.
Open AccessSelphi: Empowering GWAS Discovery through Enhanced Genotype Imputation
Motivation: Genotype imputation is a powerful tool for inferring missing genotype data in large-scale genomic studies. Over the last two decades, multiple research groups have developed a number of imputation algorithms, which continue improving in speed and overall accuracy. However, accurate imputation of rare and infrequent variants remains a challenge. Results: Here we present Selphi, a novel genotype imputation algorithm based on the Positional Burrow Wheeler Transform (PBWT) and a new heuristic method for haplotype selection based on identity by descent (IBD). When compared to state-of-the-art methods Beagle5.4, IMPUTE5, and Minimac4, Selphi showed a higher accuracy in 1000 Genome Project and TOPmed datasets, across all super-populations and allele frequencies. Similarly, Selphi performed better than Beagle5.4 in the UK Biobank dataset, which translated into improved GWAS discovery and more accurate polygenic risk scores. Selphi’s improvements in imputation accuracy, especially for rare and low frequency variants, promises to boost the power and accuracy of downstream genomic applications. Availability and implementation: Selphi code is available at GitHub: https://github.com/selfdecode/rd-imputation-selphi . Additionally, we offer an applet that allows convenient testing of the Selphi code on the UKB RAP platform.
- Open Access
Retracing Human Genetic Histories and Natural Selection Using Precise Local Ancestry Inference
In an increasingly diverse world, including admixed individuals in genomic studies is imperative for equity and portability. A crucial first step is precise local ancestry inference (LAI). We have developed Orchestra, a LAI model with unprecedented accuracy, and trained on over 10,000 single-origin individuals from 35 worldwide populations. We employed Orchestra to delve into genetic relationships and demographic histories, with a focus on Latin Americans, a prime example of admixture, and the Ashkenazi Jewish, whose origins have long been debated. Finally, Orchestra enabled us to map signatures of selection, notably identifying trace Scandinavian ancestry in British samples and unveiling an immune-rich region linked to respiratory infections. Our work advances the field of LAI and holds promise for improvements in future applications for admixed populations. One-Sentence Summary Orchestra unveils Latino and Ashkenazi ancestral roots and a candidate Viking locus under selection in the British population
Open AccessRetracing Human Genetic Histories and Natural Selection Using Precise Local Ancestry Inference
In an increasingly diverse world, including admixed individuals in genomic studies is imperative for equity and portability. A crucial first step is precise local ancestry inference (LAI). We have developed Orchestra, a LAI model with unprecedented accuracy, and trained on over 10,000 single-origin individuals from 35 worldwide populations. We employed Orchestra to delve into genetic relationships and demographic histories, with a focus on Latin Americans, a prime example of admixture, and the Ashkenazi Jewish, whose origins have long been debated. Finally, Orchestra enabled us to map signatures of selection, notably identifying trace Scandinavian ancestry in British samples and unveiling an immune-rich region linked to respiratory infections. Our work advances the field of LAI and holds promise for improvements in future applications for admixed populations. One-Sentence Summary Orchestra unveils Latino and Ashkenazi ancestral roots and a candidate Viking locus under selection in the British population
- Open Access
- 19 October 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (10) , e0260177
A comparative analysis of current phasing and imputation software
Whole-genome data has become significantly more accessible over the last two decades. This can largely be attributed to both reduced sequencing costs and imputation models which make it possible to obtain nearly whole-genome data from less expensive genotyping methods, such as microarray chips. Although there are many different approaches to imputation, the Hidden Markov Model (HMM) remains the most widely used. In this study, we compared the latest versions of the most popular HMM-based tools for phasing and imputation: Beagle5.4, Eagle2.4.1, Shapeit4, Impute5 and Minimac4. We benchmarked them on four input datasets with three levels of chip density. We assessed each imputation software on the basis of accuracy, speed and memory usage, and showed how the choice of imputation accuracy metric can result in different interpretations. The highest average concordance rate was achieved by Beagle5.4, followed by Impute5 and Minimac4, using a reference-based approach during phasing and the highest density chip. IQS and R2 metrics revealed that Impute5 and Minimac4 obtained better results for low frequency markers, while Beagle5.4 remained more accurate for common markers (MAF>5%). Computational load as measured by run time was lower for Beagle5.4 than Minimac4 and Impute5, while Minimac4 utilized the least memory of the imputation tools we compared. ShapeIT4, used the least memory of the phasing tools examined with genotype chip data, while Eagle2.4.1 used the least memory phasing WGS data. Finally, we determined the combination of phasing software, imputation software, and reference panel, best suited for different situations and analysis needs and created an automated pipeline that provides a way for users to create customized chips designed to optimize their imputation results.
- 19 October 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (10) , e0260177
Open AccessA comparative analysis of current phasing and imputation software
Whole-genome data has become significantly more accessible over the last two decades. This can largely be attributed to both reduced sequencing costs and imputation models which make it possible to obtain nearly whole-genome data from less expensive genotyping methods, such as microarray chips. Although there are many different approaches to imputation, the Hidden Markov Model (HMM) remains the most widely used. In this study, we compared the latest versions of the most popular HMM-based tools for phasing and imputation: Beagle5.4, Eagle2.4.1, Shapeit4, Impute5 and Minimac4. We benchmarked them on four input datasets with three levels of chip density. We assessed each imputation software on the basis of accuracy, speed and memory usage, and showed how the choice of imputation accuracy metric can result in different interpretations. The highest average concordance rate was achieved by Beagle5.4, followed by Impute5 and Minimac4, using a reference-based approach during phasing and the highest density chip. IQS and R2 metrics revealed that Impute5 and Minimac4 obtained better results for low frequency markers, while Beagle5.4 remained more accurate for common markers (MAF>5%). Computational load as measured by run time was lower for Beagle5.4 than Minimac4 and Impute5, while Minimac4 utilized the least memory of the imputation tools we compared. ShapeIT4, used the least memory of the phasing tools examined with genotype chip data, while Eagle2.4.1 used the least memory phasing WGS data. Finally, we determined the combination of phasing software, imputation software, and reference panel, best suited for different situations and analysis needs and created an automated pipeline that provides a way for users to create customized chips designed to optimize their imputation results.
- Open Access
A comparative analysis of current phasing and imputation software
Whole-genome data has become significantly more accessible over the last two decades. This can largely be attributed to both reduced sequencing costs and imputation models which make it possible to obtain nearly whole-genome data from less expensive genotyping methods, such as microarray chips. Although there are many different approaches to imputation, the Hidden Markov Model remains the most widely used. In this study, we compared the latest versions of the most popular Hidden Markov Model based tools for phasing and imputation: Beagle 5.2, Eagle 2.4.1, Shapeit 4, Impute 5 and Minimac 4. We benchmarked them on three input datasets with three levels of chip density. We assessed each imputation software on the basis of accuracy, speed and memory usage, and showed how the choice of imputation accuracy metric can result in different interpretations. The highest average concordance rate was achieved by Beagle 5.2, followed by Impute 5 and Minimac 4, using a reference-based approach during phasing and the highest density chip. IQS and R 2 metrics revealed that IMPUTE5 obtained better results for low frequency markers, while Beagle 5.2 remained more accurate for common markers (MAF>5%). Computational load as measured by run time was lower for Beagle 5.2 than Impute 5 and Minimac 4, while Minimac utilized the least memory of the imputation tools we compared. ShapeIT 4, used the least memory of the phasing tools examined, even with the highest density chip. Finally, we determined the combination of phasing software, imputation software, and reference panel, best suited for different situations and analysis needs and created an automated pipeline that provides a way for users to create customized chips designed to optimize their imputation results.
Open AccessA comparative analysis of current phasing and imputation software
Whole-genome data has become significantly more accessible over the last two decades. This can largely be attributed to both reduced sequencing costs and imputation models which make it possible to obtain nearly whole-genome data from less expensive genotyping methods, such as microarray chips. Although there are many different approaches to imputation, the Hidden Markov Model remains the most widely used. In this study, we compared the latest versions of the most popular Hidden Markov Model based tools for phasing and imputation: Beagle 5.2, Eagle 2.4.1, Shapeit 4, Impute 5 and Minimac 4. We benchmarked them on three input datasets with three levels of chip density. We assessed each imputation software on the basis of accuracy, speed and memory usage, and showed how the choice of imputation accuracy metric can result in different interpretations. The highest average concordance rate was achieved by Beagle 5.2, followed by Impute 5 and Minimac 4, using a reference-based approach during phasing and the highest density chip. IQS and R 2 metrics revealed that IMPUTE5 obtained better results for low frequency markers, while Beagle 5.2 remained more accurate for common markers (MAF>5%). Computational load as measured by run time was lower for Beagle 5.2 than Impute 5 and Minimac 4, while Minimac utilized the least memory of the imputation tools we compared. ShapeIT 4, used the least memory of the phasing tools examined, even with the highest density chip. Finally, we determined the combination of phasing software, imputation software, and reference panel, best suited for different situations and analysis needs and created an automated pipeline that provides a way for users to create customized chips designed to optimize their imputation results.
- 1 September 2020
- Published by Elsevier in Fertility and Sterility
- Vol. 114 (3) , e238
GENOMICS ANALYSIS OF MATERNAL EXOMES REVEALS NEW CANDIDATE GENES AND PATHWAYS FOR THE DIAGNOSIS AND PREDICTION OF RECURRENT PREIMPLANTATION EMBRYO ARREST IN IVF CYCLES
- 1 September 2020
- Published by Elsevier in Fertility and Sterility
- Vol. 114 (3) , e238
GENOMICS ANALYSIS OF MATERNAL EXOMES REVEALS NEW CANDIDATE GENES AND PATHWAYS FOR THE DIAGNOSIS AND PREDICTION OF RECURRENT PREIMPLANTATION EMBRYO ARREST IN IVF CYCLES